What is Urinary Incontinence?

Urinary incontinence is the involuntary loss of urine from the bladder typically caused by weak or overactive bladder muscles.

There are different types of urinary leakage in women.

Stress incontinence – the involuntary loss of urine due to movements and activities that cause abdominal pressure such as coughing, sneezing and lifting (common in women)

Urge incontinence – often referred to as “overactive bladder,” the feeling of a strong and sudden need to urinate

Mixed incontinence – a combination of stress and urge incontinence

Overflow incontinence – the involuntary release of urine as a result of a full bladder

Functional incontinence – a physical problem keeps the person from making it to the restroom quickly enough

Total incontinence – continuous urinary leakage and total loss of control

Can incontinence be treated?

Fortunately, incontinence can be treated. We offer two treatment options for incontinence. The first is through the use of Platelet Rich Plasma (PRP) women have been successfully treated for urinary incontinence. Administered through the O-Shot ®, PRP triggers the release of growth and healing factors that stimulate the tissue to rejuvenate.

Relief is typically experienced within 1-2 weeks following the O-Shot ®, and improvement continues over several weeks. Many patients have even had success resulting in reduced or eliminated need for medications used for treatment for urinary incontinence. Some have reported that they have completely stopped leaking urine after the O-Shot ®.

The second is with the Viveve ® Treatment. The Viveve ® System is a patented, cryogen-cooled monopolar, radiofrequence (RF) energy deliver system. Controlled-cooling protects the tissue surfaces from any damage and impacts the resistance of the epithelial layer which allows for greater penetration of the RF energy. RF consistently and safely delivers 90J/cm2 of energy deep into the tissue. Women have reported significant improvement with the Viveve ® treatment with results starting as early as within 2 weeks and continuing to improve as the cells repair for the next six months.

In a recent study reported by the Viveve ® company, 72% of patients treated experienced an improvement from baseline in the 1-hour Pad Weight Test at 12 months and a whopping 60% of patients experienced significant benefit as they had less than one gram of urine leakage in the 1-hour Pad Weight Test at 12 months.

Are these treatments right for me?

Urinary incontinence can affect females of all ages, especially aging women and those who have given birth. The O-Shot ® and the Viveve ® treatment are revolutionary treatments and each individual will respond differently. It is strongly recommended that patients should discuss the options with a qualified physician.